EP08.02-146 Proposal of Foretinib as Second-Line TKI after Capmatinib/Tepotinib Treatment Failure in NSCLC with MET Exon 14 Mutation.

Details

Language :

English

ISSN :

15560864

Volume :

17

Issue :

9

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

159038075

Full Text :

https://doi.org/10.1016/j.jtho.2022.07.829